Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Janssen Research & Development, LLC
Meletios A Dimopoulos; Peter M Voorhees; Fredrik Schjesvold; Yael C Cohen; Vania Hungria; Irwindeep Sandhu; Jindriska Lindsay; Ross I Baker; Kenshi Suzuki; Hiroshi Kosugi; Mark-David Levin; Meral Beksac; Keith Stockerl-Goldstein; Albert Oriol; Gabor Mikala; Gonzalo Garate; Koen Theunissen; Ivan Spicka; Anne K Mylin; Sara Bringhen; Katarina Uttervall; Bartosz Pula; Eva Medvedova; Andrew J Cowan; Philippe Moreau; Maria-Victoria Mateos; Hartmut Goldschmidt; Tahamtan Ahmadi; Linlin Sha; Annelore Cortoos; Eva G Katz; Els Rousseau; Liang Li; Robyn M Dennis; Robin Carson; S Vincent Rajkumar; AQUILA Investigators